{"id":45974,"date":"2025-11-06T11:27:09","date_gmt":"2025-11-06T03:27:09","guid":{"rendered":"https:\/\/flcube.com\/?p=45974"},"modified":"2025-11-06T11:27:10","modified_gmt":"2025-11-06T03:27:10","slug":"shandong-jincheng-pharma-subsidiary-jincheng-taier-to-sell-proxyl-vaginal-capsule-tech-mah-rights-to-shanghai-hemony-for-rmb-50-m","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=45974","title":{"rendered":"Shandong Jincheng Pharma Subsidiary Jincheng Taier to Sell Proxyl Vaginal Capsule Tech &amp; MAH Rights to Shanghai Hemony for RMB\u202f50\u202fM"},"content":{"rendered":"\n<p><strong>Shandong Jincheng Pharmaceutical Group Co., Ltd. (<a href=\"https:\/\/www.google.com\/finance\/quote\/300233:SHE\">SHE: 300233<\/a>)<\/strong> disclosed that its wholly\u2011owned subsidiary <strong>Jincheng Taier<\/strong> has signed an agreement to transfer the <strong>\u201cProxyl Estrogen Vaginal Soft Capsule\u201d production technology and Marketing Authorization Holder (MAH) rights<\/strong> to <strong>Shanghai Hemony Pharmaceutical Co., Ltd.<\/strong>. The transaction is valued at <strong>RMB\u202f50\u202fmillion<\/strong> and is expected to close by the end of Q4\u202f2025.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-transaction-details\">Transaction Details<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Description<\/th><\/tr><\/thead><tbody><tr><td><strong>Seller<\/strong><\/td><td>Jincheng Taier (subsidiary of Shandong Jincheng Pharma)<\/td><\/tr><tr><td><strong>Buyer<\/strong><\/td><td>Shanghai Hemony Pharmaceutical Co., Ltd.<\/td><\/tr><tr><td><strong>Asset<\/strong><\/td><td>Production technology &amp; MAH rights for Proxyl Estrogen Vaginal Soft Capsule<\/td><\/tr><tr><td><strong>Consideration<\/strong><\/td><td>RMB\u202f50\u202fmillion (\u2248\u202fUS$7.0\u202fmillion)<\/td><\/tr><tr><td><strong>Closing Window<\/strong><\/td><td>Expected Q4\u202f2025<\/td><\/tr><tr><td><strong>Regulatory Status<\/strong><\/td><td>Approved in China (Dec\u202f2005), valid through May\u202f2030 (Approval No.\u202f[redacted])<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-product-background\">Product Background<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Proxyl Estrogen Vaginal Soft Capsule<\/strong> \u2013 Indicated for:<\/li>\n<\/ul>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Vaginal atrophy caused by estrogen deficiency.<\/li>\n\n\n\n<li>Persistent, unhealed lesions or delayed scabbing of the cervix, vagina, or vulval mucosa following childbirth, local surgery, or physical\u2011therapy procedures (laser, cryotherapy, cauterization, etc.).<\/li>\n<\/ol>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Competitive Landscape<\/strong> \u2013 Jincheng Taier also markets <strong>Proxyl Estrogen Cream<\/strong>. Because both products are manufactured at a single site, the soft\u2011capsule formulation offers no clear promotional or clinical advantage over the cream, leading to internal competition.<\/li>\n\n\n\n<li><strong>Financial Impact<\/strong> \u2013 In 2024, sales of the vaginal soft capsule accounted for <strong>\u2248\u202f1.05\u202f%<\/strong> of Shandong Jincheng\u2019s total operating revenue, underscoring its modest contribution to the group\u2019s topline.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-rationale\">Strategic Rationale<\/h2>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Portfolio Rationalisation<\/strong> \u2013 Divesting the low\u2011margin capsule line allows Jincheng Taier to concentrate resources on the higher\u2011volume cream product and other growth assets.<\/li>\n\n\n\n<li><strong>Capital Reallocation<\/strong> \u2013 The RMB\u202f50\u202fmillion proceeds can be redeployed into R&amp;D pipelines, new product launches, or debt reduction.<\/li>\n\n\n\n<li><strong>Buyer\u2019s Expansion<\/strong> \u2013 Shanghai Hemony gains a fully approved, niche estrogen\u2011therapy product with an existing MAH framework, accelerating its entry into the women\u2019s\u2011health market.<\/li>\n<\/ol>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-amp-regulatory-outlook\">Market &amp; Regulatory Outlook<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Regulatory Timeline<\/strong> \u2013 The MAH transfer will require approval from the <strong>National Medical Products Administration (NMPA)<\/strong>. Given the existing approval (valid until May\u202f2030), the process is expected to be straightforward.<\/li>\n\n\n\n<li><strong>Revenue Forecast<\/strong> \u2013 Post\u2011transfer, Jincheng Taier will lose the capsule\u2019s modest revenue stream but may improve overall margin by eliminating duplicated marketing and sales efforts.<\/li>\n\n\n\n<li><strong>Industry Implication<\/strong> \u2013 The deal highlights a broader trend of Chinese pharma groups pruning non\u2011core assets and focusing on scalable, high\u2011margin products.<\/li>\n<\/ul>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding the transaction timeline, financial impact, and regulatory expectations. Actual results may differ due to market conditions, regulatory review outcomes, and the execution of the asset transfer.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/\u91d1\u57ce\u533b\u836f\uff1a\u5173\u4e8e\u8f6c\u8ba9\u836f\u54c1\u751f\u4ea7\u6280\u672f\u53ca\u4e0a\u5e02\u8bb8\u53ef\u6301\u6709\u4eba\u6743\u76ca\u7684\u516c\u544a.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of \u91d1\u57ce\u533b\u836f\uff1a\u5173\u4e8e\u8f6c\u8ba9\u836f\u54c1\u751f\u4ea7\u6280\u672f\u53ca\u4e0a\u5e02\u8bb8\u53ef\u6301\u6709\u4eba\u6743\u76ca\u7684\u516c\u544a.\"><\/object><a id=\"wp-block-file--media-86588bd7-eeab-4be1-80a7-793631bfcd48\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/\u91d1\u57ce\u533b\u836f\uff1a\u5173\u4e8e\u8f6c\u8ba9\u836f\u54c1\u751f\u4ea7\u6280\u672f\u53ca\u4e0a\u5e02\u8bb8\u53ef\u6301\u6709\u4eba\u6743\u76ca\u7684\u516c\u544a.pdf\">\u91d1\u57ce\u533b\u836f\uff1a\u5173\u4e8e\u8f6c\u8ba9\u836f\u54c1\u751f\u4ea7\u6280\u672f\u53ca\u4e0a\u5e02\u8bb8\u53ef\u6301\u6709\u4eba\u6743\u76ca\u7684\u516c\u544a<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/\u91d1\u57ce\u533b\u836f\uff1a\u5173\u4e8e\u8f6c\u8ba9\u836f\u54c1\u751f\u4ea7\u6280\u672f\u53ca\u4e0a\u5e02\u8bb8\u53ef\u6301\u6709\u4eba\u6743\u76ca\u7684\u516c\u544a.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-86588bd7-eeab-4be1-80a7-793631bfcd48\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Shandong Jincheng Pharmaceutical Group Co., Ltd. (SHE: 300233) disclosed that its wholly\u2011owned subsidiary Jincheng Taier&#8230;<\/p>\n","protected":false},"author":1,"featured_media":45977,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[4436,2910,934],"class_list":["post-45974","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-hemony-pharmaceutical","tag-jincheng-pharmaceutical","tag-she-300233"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Shandong Jincheng Pharma Subsidiary Jincheng Taier to Sell Proxyl Vaginal Capsule Tech &amp; MAH Rights to Shanghai Hemony for RMB\u202f50\u202fM - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Shandong Jincheng Pharmaceutical Group Co., Ltd. (SHE: 300233) disclosed that its wholly\u2011owned subsidiary Jincheng Taier has signed an agreement to transfer the \u201cProxyl Estrogen Vaginal Soft Capsule\u201d production technology and Marketing Authorization Holder (MAH) rights to Shanghai Hemony Pharmaceutical Co., Ltd.. The transaction is valued at RMB\u202f50\u202fmillion and is expected to close by the end of Q4\u202f2025.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=45974\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Shandong Jincheng Pharma Subsidiary Jincheng Taier to Sell Proxyl Vaginal Capsule Tech &amp; MAH Rights to Shanghai Hemony for RMB\u202f50\u202fM\" \/>\n<meta property=\"og:description\" content=\"Shandong Jincheng Pharmaceutical Group Co., Ltd. (SHE: 300233) disclosed that its wholly\u2011owned subsidiary Jincheng Taier has signed an agreement to transfer the \u201cProxyl Estrogen Vaginal Soft Capsule\u201d production technology and Marketing Authorization Holder (MAH) rights to Shanghai Hemony Pharmaceutical Co., Ltd.. The transaction is valued at RMB\u202f50\u202fmillion and is expected to close by the end of Q4\u202f2025.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=45974\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-06T03:27:09+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-06T03:27:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0601.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45974#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45974\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Shandong Jincheng Pharma Subsidiary Jincheng Taier to Sell Proxyl Vaginal Capsule Tech &amp; MAH Rights to Shanghai Hemony for RMB\u202f50\u202fM\",\"datePublished\":\"2025-11-06T03:27:09+00:00\",\"dateModified\":\"2025-11-06T03:27:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45974\"},\"wordCount\":429,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45974#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0601.webp\",\"keywords\":[\"Hemony Pharmaceutical\",\"Jincheng Pharmaceutical\",\"SHE: 300233\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=45974#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45974\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=45974\",\"name\":\"Shandong Jincheng Pharma Subsidiary Jincheng Taier to Sell Proxyl Vaginal Capsule Tech &amp; MAH Rights to Shanghai Hemony for RMB\u202f50\u202fM - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45974#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45974#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0601.webp\",\"datePublished\":\"2025-11-06T03:27:09+00:00\",\"dateModified\":\"2025-11-06T03:27:10+00:00\",\"description\":\"Shandong Jincheng Pharmaceutical Group Co., Ltd. (SHE: 300233) disclosed that its wholly\u2011owned subsidiary Jincheng Taier has signed an agreement to transfer the \u201cProxyl Estrogen Vaginal Soft Capsule\u201d production technology and Marketing Authorization Holder (MAH) rights to Shanghai Hemony Pharmaceutical Co., Ltd.. The transaction is valued at RMB\u202f50\u202fmillion and is expected to close by the end of Q4\u202f2025.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45974#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=45974\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45974#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0601.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0601.webp\",\"width\":1080,\"height\":608,\"caption\":\"Shandong Jincheng Pharma Subsidiary Jincheng Taier to Sell Proxyl Vaginal Capsule Tech & MAH Rights to Shanghai Hemony for RMB\u202f50\u202fM\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45974#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shandong Jincheng Pharma Subsidiary Jincheng Taier to Sell Proxyl Vaginal Capsule Tech &amp; MAH Rights to Shanghai Hemony for RMB\u202f50\u202fM\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Shandong Jincheng Pharma Subsidiary Jincheng Taier to Sell Proxyl Vaginal Capsule Tech &amp; MAH Rights to Shanghai Hemony for RMB\u202f50\u202fM - Insight, China&#039;s Pharmaceutical Industry","description":"Shandong Jincheng Pharmaceutical Group Co., Ltd. (SHE: 300233) disclosed that its wholly\u2011owned subsidiary Jincheng Taier has signed an agreement to transfer the \u201cProxyl Estrogen Vaginal Soft Capsule\u201d production technology and Marketing Authorization Holder (MAH) rights to Shanghai Hemony Pharmaceutical Co., Ltd.. The transaction is valued at RMB\u202f50\u202fmillion and is expected to close by the end of Q4\u202f2025.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=45974","og_locale":"en_US","og_type":"article","og_title":"Shandong Jincheng Pharma Subsidiary Jincheng Taier to Sell Proxyl Vaginal Capsule Tech &amp; MAH Rights to Shanghai Hemony for RMB\u202f50\u202fM","og_description":"Shandong Jincheng Pharmaceutical Group Co., Ltd. (SHE: 300233) disclosed that its wholly\u2011owned subsidiary Jincheng Taier has signed an agreement to transfer the \u201cProxyl Estrogen Vaginal Soft Capsule\u201d production technology and Marketing Authorization Holder (MAH) rights to Shanghai Hemony Pharmaceutical Co., Ltd.. The transaction is valued at RMB\u202f50\u202fmillion and is expected to close by the end of Q4\u202f2025.","og_url":"https:\/\/flcube.com\/?p=45974","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-11-06T03:27:09+00:00","article_modified_time":"2025-11-06T03:27:10+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0601.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=45974#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=45974"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Shandong Jincheng Pharma Subsidiary Jincheng Taier to Sell Proxyl Vaginal Capsule Tech &amp; MAH Rights to Shanghai Hemony for RMB\u202f50\u202fM","datePublished":"2025-11-06T03:27:09+00:00","dateModified":"2025-11-06T03:27:10+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=45974"},"wordCount":429,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=45974#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0601.webp","keywords":["Hemony Pharmaceutical","Jincheng Pharmaceutical","SHE: 300233"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=45974#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=45974","url":"https:\/\/flcube.com\/?p=45974","name":"Shandong Jincheng Pharma Subsidiary Jincheng Taier to Sell Proxyl Vaginal Capsule Tech &amp; MAH Rights to Shanghai Hemony for RMB\u202f50\u202fM - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=45974#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=45974#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0601.webp","datePublished":"2025-11-06T03:27:09+00:00","dateModified":"2025-11-06T03:27:10+00:00","description":"Shandong Jincheng Pharmaceutical Group Co., Ltd. (SHE: 300233) disclosed that its wholly\u2011owned subsidiary Jincheng Taier has signed an agreement to transfer the \u201cProxyl Estrogen Vaginal Soft Capsule\u201d production technology and Marketing Authorization Holder (MAH) rights to Shanghai Hemony Pharmaceutical Co., Ltd.. The transaction is valued at RMB\u202f50\u202fmillion and is expected to close by the end of Q4\u202f2025.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=45974#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=45974"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=45974#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0601.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0601.webp","width":1080,"height":608,"caption":"Shandong Jincheng Pharma Subsidiary Jincheng Taier to Sell Proxyl Vaginal Capsule Tech & MAH Rights to Shanghai Hemony for RMB\u202f50\u202fM"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=45974#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Shandong Jincheng Pharma Subsidiary Jincheng Taier to Sell Proxyl Vaginal Capsule Tech &amp; MAH Rights to Shanghai Hemony for RMB\u202f50\u202fM"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0601.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/45974","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=45974"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/45974\/revisions"}],"predecessor-version":[{"id":45978,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/45974\/revisions\/45978"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/45977"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=45974"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=45974"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=45974"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}